Literature DB >> 22467921

Effect of rheumatoid arthritis on volumetric bone mineral density and bone geometry, assessed by peripheral quantitative computed tomography in postmenopausal women treated with bisphosphonates.

Symeon Tournis1, Vasilios Samdanis, Savas Psarelis, Chrysa Liakou, Julia Antoniou, Thomas Georgoulas, Ismini Dontas, Nikolaos Papaioannou, Susan Gazi, George P Lyritis.   

Abstract

OBJECTIVE: To investigate the effect of rheumatoid arthritis (RA) on volumetric bone mineral density (vBMD) and bone geometry in postmenopausal women treated with bisphosphonates.
METHODS: Fifty-three postmenopausal women with RA and 87 control subjects, comparable in terms of age, body mass index, and years since menopause, underwent peripheral quantitative computed tomography (pQCT) of the nondominant tibia.
RESULTS: At 4% (trabecular site), trabecular bone mineral content (BMC) and vBMD (p < 0.001) were lower in the RA group, while trabecular area was comparable. At 38% (cortical site), cortical BMC (p < 0.01), area (p < 0.05), and thickness (p < 0.001) were lower in the RA group, whereas vBMD was comparable. Endosteal circumference was higher (p < 0.05), whereas periosteal circumference was comparable, indicating cancellization of cortical bone. In the RA group, muscle area was lower (p < 0.001), while at 14% polar stress strength index was significantly lower (p < 0.01) in patients with RA, indicating impairment of bone mechanical properties.
CONCLUSION: RA is associated with negative effects on both cortical and cancellous bone in postmenopausal women treated with bisphosphonates. Cortical geometric properties are also adversely affected mainly by increased endosteal circumference, whereas trabecular geometric properties are generally preserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22467921     DOI: 10.3899/jrheum.110579

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  3 in total

Review 1.  Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment.

Authors:  Georg Schett; Ellen Gravallese
Journal:  Nat Rev Rheumatol       Date:  2012-09-25       Impact factor: 20.543

2.  Influence of bisphosphonate therapy on bone geometry, volumetric bone density and bone strength of femoral shaft in postmenopausal women with rheumatoid arthritis.

Authors:  Rahel Meinen; Inna Galli-Lysak; Peter M Villiger; Daniel Aeberli
Journal:  BMC Musculoskelet Disord       Date:  2016-08-05       Impact factor: 2.362

Review 3.  Cortical remodeling during menopause, rheumatoid arthritis, glucocorticoid and bisphosphonate therapy.

Authors:  Daniel Aeberli; Georg Schett
Journal:  Arthritis Res Ther       Date:  2013-03-21       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.